Hallmark #3 of 12
When gene expression drifts from its youthful pattern
Your DNA sequence doesn't change — but which genes are active does. Methylation patterns drift with age, silencing youthful genes and reactivating pro-aging ones. Horvath's clock reads this drift to the year.
Epigenetic Alterations
Epigenetic clocks (Horvath, GrimAge, DunedinPACE) predict all-cause mortality and disease risk independent of chronological age — they capture accumulated transcriptional drift better than any single biomarker. The most actionable insight is that AKG and NAD+ hit two of the three epigenetic enzyme classes (TET and sirtuins) — stacking Ca-AKG + NMN targets both the methylation and acetylation drift pathways simultaneously. GrimAge and DunedinPACE panels are now consumer-accessible and can quantify intervention response at 6-month intervals.
3 compound interventions · 2 trackable biomarkers
Top interventions
- ACa-AKG
- ANMN → SIRT1 epigenetic control
- BResveratrol → SIRT1 activation
- ACaloric moderation / fasting
- BEpigenetic clock testing
The Mechanism
The epigenetic clock — and why it’s partially reversible
Epigenetic aging is the progressive drift of DNA methylation patterns away from youthful states. CpG sites — dinucleotide positions where a cytosine precedes a guanine — can be methylated (gene-silencing) or unmethylated (gene-activating). In young cells, this pattern is tightly regulated by DNMT3 (methylation) and TET (demethylation) enzymes.
With age, three disruptions occur simultaneously: global hypomethylation— transposable elements and repetitive sequences are de-repressed, fueling genomic instability; promoter hypermethylation — tumor suppressors and longevity genes are silenced; and heterochromatin dissolution — structural chromatin loses its H3K9me3 marks as SIRT1 activity falls with NAD+.
Steve Horvath’s 2013 discovery (Genome Biology) identified 353 CpG sites whose methylation state predicts age with a median error of 3.6 years across all tissues. Subsequent clocks (GrimAge, DunedinPACE) refined this to predict mortality and pace of aging respectively.
The most important finding: epigenetic age is partially reversible. Yamanaka factor reprogramming (Oct4, Sox2, Klf4) resets methylation to embryonic patterns in mice — restoring vision and cognition. The Horvath/Sinclair “Information Theory of Aging” frames this as recoverable signal, not irreversible entropy. AKG supplementation in humans already shows 8-year epigenetic age reduction in a controlled trial.
Monitoring
Epigenetic clocks and biomarkers
Evidence-Graded Interventions
Epigenetic reprogramming with clinical evidence
Ca-AKG
Tier AAKG is a cofactor for TET dioxygenases that regulate DNA demethylation. Mouse lifespan extension data.
NMN → SIRT1 epigenetic control
Tier ANAD+-dependent sirtuins regulate histone acetylation and heterochromatin stability.
Resveratrol → SIRT1 activation
Tier BPhytoalexin that activates SIRT1; synergistic with NAD+ precursors for epigenetic remodeling.
Caloric moderation / fasting
Tier AFasting resets methylation patterns in animal models and reduces epigenetic age in pilot human studies.
Epigenetic clock testing
Tier BGrimAge, DunedinPACE, or TruAge panels to track intervention response over 6–12 months.
Slow your epigenetic clock.
Build a Ca-AKG + NMN + resveratrol protocol and track your biological age with the Bio Age Engine.